ebselen has been researched along with Insulin Resistance in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Polianskyte-Prause, Z | 1 |
| Tolvanen, TA | 1 |
| Lindfors, S | 1 |
| Kon, K | 1 |
| Hautala, LC | 1 |
| Wang, H | 1 |
| Wada, T | 1 |
| Tsuneki, H | 1 |
| Sasaoka, T | 1 |
| Lehtonen, S | 1 |
1 other study available for ebselen and Insulin Resistance
| Article | Year |
|---|---|
Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Inflammation; Insulin; Insulin Resistance; Isoindoles; Mic | 2022 |